Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 11 March 2025 regarding irrevocable undertakings from certain existing shareholders for a total ...

The board of directors of the Company has resolved not to proceed with the Subsequent Offering. The background for the cancellation is that the Company's shares have traded at or below the ...

The board of directors of the Company has resolved not to proceed with the Subsequent Offering. The background for the cancellation is that the Company's shares have traded at or below the ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION ...

The subsequent offering period for the Offer, which commenced on January 22, 2018, expired as scheduled at 12:00 midnight, New York City time, on January 31, 2018. According to Novartis ...

Permitting issuers to submit draft registration statements regardless of how much time has passed since they become subject to Exchange Act reporting requirements Expanding the availability of the ...